Published in J Virol on August 01, 2000
T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesis. J Virol (2004) 4.02
HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells. Blood (2006) 2.58
Selected Toll-like receptor ligands and viruses promote helper-independent cytotoxic T cell priming by upregulating CD40L on dendritic cells. Immunity (2009) 1.85
Portable flanking sequences modulate CTL epitope processing. J Clin Invest (2007) 1.72
HIV-induced type I interferon and tryptophan catabolism drive T cell dysfunction despite phenotypic activation. PLoS One (2008) 1.61
Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection. J Exp Med (2008) 1.54
Inhibition of indoleamine 2,3-dioxygenase (IDO) enhances elimination of virus-infected macrophages in an animal model of HIV-1 encephalitis. Blood (2005) 1.54
Regulation of virus-specific CD4+ T cell function by multiple costimulatory receptors during chronic HIV infection. J Immunol (2010) 1.28
CD127 expression and regulation are altered in the memory CD8 T cells of HIV-infected patients--reversal by highly active anti-retroviral therapy (HAART). Clin Exp Immunol (2006) 1.26
Antiviral CD8+ T cell responses in neonatal mice: susceptibility to polyoma virus-induced tumors is associated with lack of cytotoxic function by viral antigen-specific T cells. J Exp Med (2001) 1.12
Increased level of arginase activity correlates with disease severity in HIV-seropositive patients. J Infect Dis (2010) 1.05
Beyond 51Cr release: New methods for assessing HIV-1-specific CD8+ T cell responses in peripheral blood and mucosal tissues. Clin Exp Immunol (2002) 1.00
Residual viral replication during antiretroviral therapy boosts human immunodeficiency virus type 1-specific CD8+ T-cell responses in subjects treated early after infection. J Virol (2002) 0.97
Increased expression of the natural killer cell inhibitory receptor CD85j/ILT2 on antigen-specific effector CD8 T cells and its impact on CD8 T-cell function. Immunology (2004) 0.95
Interleukin-21 and cellular activation concurrently induce potent cytotoxic function and promote antiviral activity in human CD8 T cells. Hum Immunol (2010) 0.92
The Role of CD4(+) and CD8(+) T Cells in Controlling HIV Infection. Curr Infect Dis Rep (2002) 0.87
A challenge for the future: aging and HIV infection. Immunol Res (2010) 0.83
Response to superantigen stimulation in peripheral blood mononuclear cells from children perinatally infected with human immunodeficiency virus and receiving highly active antiretroviral therapy. Clin Diagn Lab Immunol (2004) 0.83
Levels of CD56+TIM-3- effector CD8 T cells distinguish HIV natural virus suppressors from patients receiving antiretroviral therapy. PLoS One (2014) 0.82
T lymphocytes from chagasic patients are activated but lack proliferative capacity and down-regulate CD28 and CD3ζ. PLoS Negl Trop Dis (2013) 0.81
Decreased 4-1BB expression on HIV-specific CD4+ T cells is associated with sustained viral replication and reduced IL-2 production. Clin Immunol (2009) 0.81
Lack of disease specificity limits the usefulness of in vitro costimulation in HIV- and HCV-infected patients. Clin Dev Immunol (2008) 0.79
Decreased NK Cell FcRgamma in HIV-1 infected individuals receiving combination antiretroviral therapy: a cross sectional study. PLoS One (2010) 0.78
Functional and molecular aspects of transient T cell unresponsiveness: role of selective interleukin-2 deficiency. Clin Exp Immunol (2003) 0.76
Improvements in Immune Function and Activation with 48-Week Darunavir/Ritonavir-Based Therapy: GRACE Substudy. ISRN AIDS (2013) 0.75
The Emerging and Diverse Roles of Src-Like Adaptor Proteins in Health and Disease. Mediators Inflamm (2015) 0.75
T cell costimulatory molecules in anti-viral immunity: Potential role in immunotherapeutic vaccines. Can J Infect Dis (2003) 0.75
Phenotypic analysis of antigen-specific T lymphocytes. Science (1996) 24.26
1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep (1992) 22.29
Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science (1997) 15.09
Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med (1998) 14.39
Signal transduction by lymphocyte antigen receptors. Cell (1994) 10.63
Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med (1997) 8.59
HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nat Med (1999) 7.77
Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat Med (1996) 7.08
HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature (1998) 6.94
Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat Med (1999) 6.09
Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science (1992) 5.94
HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature (1988) 5.45
Brefeldin A causes disassembly of the Golgi complex and accumulation of secretory proteins in the endoplasmic reticulum. J Biol Chem (1988) 5.18
The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses. J Exp Med (1998) 4.80
Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. Immunity (1996) 4.68
Viral strategies of immune evasion. Science (1998) 4.48
Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. J Immunol (1989) 4.17
Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study. N Engl J Med (1995) 4.06
Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. J Clin Invest (1997) 4.01
CD8 naive T cell counts decrease progressively in HIV-infected adults. J Clin Invest (1995) 3.97
Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy. J Virol (1999) 3.79
Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1. J Exp Med (1994) 2.81
Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors. Proc Natl Acad Sci U S A (1995) 2.30
Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma. Cancer Res (1993) 2.01
Anergy and apoptosis in CD8+ T cells from HIV-infected persons. J Immunol (1994) 2.00
Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens. J Immunol (1993) 1.98
Lymphocyte activation in HIV-1 infection. II. Functional defects of CD28- T cells. AIDS (1994) 1.93
Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain. J Clin Invest (1998) 1.80
HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment. Comet Study Group. AIDS (1999) 1.75
A transgenic mouse model to analyze CD8(+) effector T cell differentiation in vivo. Proc Natl Acad Sci U S A (1999) 1.62
Characterization of HIV-1-specific T-helper cells in acute and chronic infection. Immunol Lett (1999) 1.54
Human CD28-CD8+ T cells contain greatly expanded functional virus-specific memory CTL clones. J Immunol (1999) 1.50
Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma. Clin Cancer Res (1996) 1.46
Absence of recoverable infectious virus and unique immune responses in an asymptomatic HIV+ long-term survivor. AIDS Res Hum Retroviruses (1994) 1.45
Increased cytolytic T lymphocyte activity and decreased B7 responsiveness are associated with CD28 down-regulation on CD8+ T cells from HIV-infected subjects. Clin Exp Immunol (1995) 1.40
Perforin is not co-expressed with granzyme A within cytotoxic granules in CD8 T lymphocytes present in lymphoid tissue during chronic HIV infection. AIDS (1999) 1.40
Defective TCR-mediated signaling in synovial T cells in rheumatoid arthritis. J Immunol (1997) 1.34
Expansion of a CD8+CD28- cell population in the blood and lung of HIV-positive patients. J Acquir Immune Defic Syndr (1993) 1.30
Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: correlation with the stage of the disease. Int J Cancer (1995) 1.29
Dynamics of fine T-cell subsets during HIV disease and after thymic ablation by mediastinal irradiation. Semin Immunol (1997) 1.23
Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoir. J Infect Dis (1999) 1.21
Direct and indirect mechanisms mediating apoptosis during HIV infection: contribution to in vivo CD4 T cell depletion. Semin Immunol (1993) 1.20
Viral-specific cytotoxic T lymphocytes lyse human immunodeficiency virus-infected primary T lymphocytes by the granule exocytosis pathway. Blood (1999) 1.19
Mechanism of HIV-1 Tat induced inhibition of antigen-specific T cell responsiveness. J Immunol (1993) 1.18
T cells from patients with Hodgkin's disease have a defective T-cell receptor zeta chain expression that is reversible by T-cell stimulation with CD3 and CD28. Blood (1996) 1.17
Massive activation of immune cells with an intact T cell repertoire in acute human immunodeficiency virus syndrome. J Infect Dis (1995) 1.16
Cytotoxic T lymphocytes from HIV-1 seropositive individuals recognize immunodominant epitopes in Gp160 and reverse transcriptase. J Immunol (1992) 1.11
Regulation of CD28 costimulation in human CD8+ T cells. J Immunol (1997) 1.06
HIV infection--induced posttranslational modification of T cell signaling molecules associated with disease progression. J Clin Invest (1996) 1.02
CD3zeta and CD28 down-modulation on CD8 T cells during viral infection. Blood (2000) 0.99
Delayed virus-specific CD8+ cytotoxic T lymphocyte activity in an HIV-infected individual with high CD4+ cell counts: correlations with various parameters of disease progression. AIDS Res Hum Retroviruses (1996) 0.96
Human immunodeficiency virus Tat induces functional unresponsiveness in T cells. J Virol (1995) 0.95
CD8+ cells and not CD4+ T cells are hyporesponsive to CD28- and CD40L-mediated activation in HIV-infected subjects. Clin Exp Immunol (1997) 0.94
Expansion of T cells negative for CD28 expression in HIV infection. Relation to activation markers and cell adhesion molecules, and correlation with prognostic markers. Med Microbiol Immunol (1996) 0.94
Hydroxyurea and didanosine long-term treatment prevents HIV breakthrough and normalizes immune parameters. AIDS Res Hum Retroviruses (1999) 0.92
Immunoregulation in cancer-bearing hosts. Down-regulation of gene expression and cytotoxic function in CD8+ T cells. J Immunol (1992) 0.92
Characterization of T cell subsets involved in the production of IFN-gamma in asymptomatic HIV-infected patients. AIDS Res Hum Retroviruses (1996) 0.90
Evidence for circulating activated cytotoxic T cells in HIV-infected subjects before the onset of opportunistic infections. Clin Exp Immunol (1990) 0.90
CD28 costimulation increases CD8+ cell suppression of HIV replication. J Immunol (1997) 0.89
Ex vivo expansion of HIV type 1-specific cytolytic T cells from HIV type 1-seropositive subjects. AIDS Res Hum Retroviruses (1995) 0.85
Correlation between disease activity and T-cell CD3 zeta chain expression in a B-cell lymphoma. Br J Haematol (1994) 0.83
Decreased expression of zeta molecules by T lymphocytes is correlated with disease progression in human immunodeficiency virus-infected persons. J Infect Dis (1999) 0.82
Single-cell analysis of lymphokine imbalance in asymptomatic HIV-1 infection: evidence for a major alteration within the CD8+ T cell subset. Clin Exp Immunol (1998) 0.82
Effective lysis of HIV-1-infected primary CD4+ T cells by a cytotoxic T-lymphocyte clone directed against a novel A2-restricted reverse-transcriptase epitope. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 0.80
Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis. Am J Med (1975) 5.41
Internet paradox. A social technology that reduces social involvement and psychological well-being? Am Psychol (1998) 4.85
Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes. J Clin Invest (2001) 4.37
Genomewide association for schizophrenia in the CATIE study: results of stage 1. Mol Psychiatry (2008) 4.14
Evaluation of a polymerase chain reaction for the diagnosis of tuberculosis. Tubercle (1991) 3.58
The association between age and health literacy among elderly persons. J Gerontol B Psychol Sci Soc Sci (2000) 3.52
Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes. Ann Intern Med (2000) 3.44
Heterozygous and homozygous alpha-antitrypsin deficiency in patients with pulmonary emphysema. N Engl J Med (1969) 3.19
Statistical shape analysis of neuroanatomical structures based on medial models. Med Image Anal (2003) 3.17
Evaluation of a Web-based introductory psychology course: I. Learning and satisfaction in on-line versus lecture courses. Behav Res Methods Instrum Comput (2000) 3.07
Molecular analysis of the Duchenne muscular dystrophy region using pulsed field gel electrophoresis. Cell (1987) 2.83
Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology (2005) 2.80
The Pumilio RNA-binding domain is also a translational regulator. Mol Cell (1998) 2.68
Molecular characterization of cell cycle gene CDC7 from Saccharomyces cerevisiae. Mol Cell Biol (1986) 2.67
The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients. J Exp Med (1996) 2.67
Impaired function of circulating HIV-specific CD8(+) T cells in chronic human immunodeficiency virus infection. Blood (2000) 2.65
Abnormalities of the septum pellucidum on MR scans in first-episode schizophrenic patients. AJNR Am J Neuroradiol (1992) 2.58
Control of HIV despite the discontinuation of antiretroviral therapy. N Engl J Med (1999) 2.54
Identification of Mycobacterium tuberculosis by polymerase chain reaction. Lancet (1990) 2.39
Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. Am J Psychiatry (2001) 2.35
Central and peripheral administration of kisspeptin-10 stimulates the hypothalamic-pituitary-gonadal axis. J Neuroendocrinol (2004) 2.27
Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA (1998) 2.16
Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection. Blood (2001) 2.13
The silent treatment: siRNAs as small molecule drugs. Gene Ther (2006) 2.12
Serum angiotensin-converting enzyme for diagnosis and therapeutic evaluation of sarcoidosis. Am Rev Respir Dis (1979) 2.04
Molecular abnormality of human alpha1-antitrypsin variant (Pi-ZZ) associated with plasma activity deficiency. Proc Natl Acad Sci U S A (1976) 2.00
Zalcitabine compared with zidovudine in patients with advanced HIV-1 infection who received previous zidovudine therapy. Ann Intern Med (1993) 1.99
Hemoglobin ontogeny during normal mouse fetal development. Proc Natl Acad Sci U S A (1979) 1.79
Differential regulation of the yeast CDC7 gene during mitosis and meiosis. Mol Cell Biol (1988) 1.76
Variants of alpha 1-antitrypsin in Puerto Rican children with asthma. Chest (1993) 1.75
CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection. Blood (2001) 1.74
Health literacy and performance on the Mini-Mental State Examination. Aging Ment Health (2002) 1.72
Depression in first-episode schizophrenia. Am J Psychiatry (1993) 1.71
Pancreatic polypeptide reduces appetite and food intake in humans. J Clin Endocrinol Metab (2003) 1.71
Evaluation of Roche Amplicor PCR assay for Mycobacterium tuberculosis. J Clin Microbiol (1996) 1.70
Imaging endogenous dopamine competition with [11C]raclopride in the human brain. Synapse (1994) 1.68
Transplantation of fetal myocardial tissue into the infarcted myocardium of rat. A potential method for repair of infarcted myocardium? Circulation (1996) 1.64
Alpha 1 -antitrypsin (A1AT) accumulation in livers of emphysematous patients with A1AT deficiency. Hum Pathol (1972) 1.64
A transgenic mouse model to analyze CD8(+) effector T cell differentiation in vivo. Proc Natl Acad Sci U S A (1999) 1.62
Ghrelin increases food intake in obese as well as lean subjects. Int J Obes (Lond) (2005) 1.62
Neural representations of hunger and satiety in Prader-Willi syndrome. Int J Obes (Lond) (2006) 1.61
Alpha 1-antitrypsin Pi-types in 965 COPD patients. Chest (1986) 1.61
Predictive value of skull radiography for intracranial injury in children with blunt head injury. Lancet (1997) 1.61
Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat--angiogenesis and angioma formation. J Am Coll Cardiol (2000) 1.58
Serologic testing for amoebiasis. Gastroenterology (1980) 1.58
Open access: the view of the Public Library of Science. J Thromb Haemost (2006) 1.55
Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study. Gut (2005) 1.49
Alpha 1 antitrypsinin the livers of patients with emphysema. Science (1972) 1.49
Functional significance of PMM2 mutations in mildly affected patients with congenital disorders of glycosylation Ia. Genet Med (2001) 1.49
Absence of recoverable infectious virus and unique immune responses in an asymptomatic HIV+ long-term survivor. AIDS Res Hum Retroviruses (1994) 1.45
Alpha(1)-antitrypsin deficiency. Calif Med (1973) 1.45
Postprandial plasma ghrelin is suppressed proportional to meal calorie content in normal-weight but not obese subjects. J Clin Endocrinol Metab (2004) 1.43
Granzyme A loading induces rapid cytolysis and a novel form of DNA damage independently of caspase activation. Immunity (1999) 1.42
Studies on the intracellular replicating DNA of herpes simplex virus type 1. Virology (1977) 1.40
Perforin is not co-expressed with granzyme A within cytotoxic granules in CD8 T lymphocytes present in lymphoid tissue during chronic HIV infection. AIDS (1999) 1.40
Identification and characteristics of the common alpha 1 -antitrypsin phenotypes. Chest (1972) 1.36
Elevation of serum angiotensin-converting enzyme in Gaucher's disease. N Engl J Med (1976) 1.35
Adenomatous tumors of the middle ear and mastoid. Am J Otol (1990) 1.34
Induction of cell-mediated immune responses to human immunodeficiency virus type 1 Gag protein by using Listeria monocytogenes as a live vaccine vector. J Immunol (1995) 1.34
Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in Senegal. Trop Med Int Health (2005) 1.34
Alpha 1 -antitrypsin deficiency. Med Clin North Am (1973) 1.32
Mitochondria-dependent and -independent regulation of Granzyme B-induced apoptosis. J Exp Med (1999) 1.31
A new deficient variant of alpha1-antitrypsin (MDUARTE). Inability to detect the heterozygous state by antitrypsin phenotyping. Am Rev Respir Dis (1976) 1.29
Inhibition of human cytochrome P450 isoforms by nonnucleoside reverse transcriptase inhibitors. J Clin Pharmacol (2001) 1.28
Cytopathogenicity of Naegleria fowleri and Naegleria gruberi for established mammalian cell cultures. J Parasitol (1982) 1.28
Relationship between psychostimulant-induced "high" and dopamine transporter occupancy. Proc Natl Acad Sci U S A (1996) 1.27
Mapping of DNA markers close to the fragile site on the human X chromosome at Xq27.3. Nucleic Acids Res (1987) 1.26
Granzyme A activates an endoplasmic reticulum-associated caspase-independent nuclease to induce single-stranded DNA nicks. J Biol Chem (2001) 1.25
An orthopaedic theatre timings survey. Ann R Coll Surg Engl (1994) 1.25
Markers of data quality in computer audit: the Manchester Orthopaedic Database. Ann R Coll Surg Engl (1993) 1.24
Polycystic liver disease: a study of cyst fluid constituents. Hepatology (1982) 1.23
Tardive dyskinesia: prevalence, incidence, and risk factors. J Clin Psychopharmacol (1988) 1.22
Special delivery: targeted therapy with small RNAs. Gene Ther (2011) 1.22
Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoir. J Infect Dis (1999) 1.21
Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors. Am J Psychiatry (1997) 1.21
The specificity and nature of serum-angiotensin-converting enzyme (serum ACE) elevations in sarcoidosis. Ann N Y Acad Sci (1976) 1.21
Usefulness of blood culture for hospitalized patients who are receiving antibiotic therapy. Clin Infect Dis (2001) 1.20
Viral-specific cytotoxic T lymphocytes lyse human immunodeficiency virus-infected primary T lymphocytes by the granule exocytosis pathway. Blood (1999) 1.19
Identification of vaccine candidate antigens from a genomic analysis of Porphyromonas gingivalis. Vaccine (2001) 1.19
Cryptosporidiosis outbreak in a day-care center. Am J Dis Child (1985) 1.18
Direct cleavage of the human DNA fragmentation factor-45 by granzyme B induces caspase-activated DNase release and DNA fragmentation. EMBO J (2001) 1.17
Integrating incidence and prevalence of tardive dyskinesia. Psychopharmacol Bull (1986) 1.17
Granzymes A and B directly cleave lamins and disrupt the nuclear lamina during granule-mediated cytolysis. Proc Natl Acad Sci U S A (2001) 1.16
Protease inhibitors as inhibitors of human cytochromes P450: high risk associated with ritonavir. J Clin Pharmacol (1998) 1.16
Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder. Acta Psychiatr Scand (2001) 1.16
Serum angiotensin-converting enzyme in leprosy and coccidioidomycosis. Ann Intern Med (1977) 1.14
Hepatocellular carcinoma and intermediate alpha1-antitrypsin deficiency (MZ phenotype). Am J Clin Pathol (1975) 1.13
Emergency thoracotomy: survival correlates with physiologic status. J Trauma (1992) 1.12
Cryotherapy compared with Robert Jones bandage after total knee replacement: a prospective randomized trial. Int Orthop (2001) 1.11
Defining the origin of Plasmodium falciparum resistant dhfr isolates in Senegal. Acta Trop (2006) 1.10
Effects of clozapine on auditory event-related potentials in schizophrenia. Biol Psychiatry (1998) 1.09
Profile of bronchospastic disease in Puerto Rican patients in New York City. A possible relationship to alpha 1-antitrypsin variants. Arch Intern Med (1990) 1.09
Angiotensin-I-converting enzyme and gallium scan in noninvasive evaluation of sarcoidosis. Ann Intern Med (1979) 1.08